<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04029311</url>
  </required_header>
  <id_info>
    <org_study_id>20170991</org_study_id>
    <nct_id>NCT04029311</nct_id>
  </id_info>
  <brief_title>Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)</brief_title>
  <official_title>Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joseph Adame</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Adame, J. Michael, D.D.S.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects of two combination therapies for patients with OSA who have been both
      intolerant to PAP therapy and sub-therapeutic to oral appliance therapy.

      Hypothesis

      1. There is a difference between CPAP vs CPAP/OA connect vs CPAP/OA disconnected in terms of:

        1. AHI reduction

        2. Amount of side effects

        3. Amount of Leaks

        4. Hours of use (compliance)

        5. CPAP pressure

      2. There is a difference between connected and disconnected for the following symptoms:

        1. ESS

        2. FOSQ

        3. Side effects Study Design - randomized prospective parallel
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 8, 2017</start_date>
  <completion_date type="Actual">May 7, 2019</completion_date>
  <primary_completion_date type="Actual">February 6, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index</measure>
    <time_frame>2 months</time_frame>
    <description>Episodes per hour that the patient experiences apneas and/or hypopneas</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PAP pressure</measure>
    <time_frame>2 months</time_frame>
    <description>The cm H2O of pressure required to treat the patient successfully</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leaks</measure>
    <time_frame>2 months</time_frame>
    <description>The Liters/Minute of leaking of the PAP machine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hours of Use</measure>
    <time_frame>2 months</time_frame>
    <description>The average hours of use per night of each of the combination therapies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ESS</measure>
    <time_frame>2 months</time_frame>
    <description>Epworth Sleepiness Scale (0-24) is a tool used to measure subjective response to a therapeutic intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FOSQ</measure>
    <time_frame>2 months</time_frame>
    <description>Functional Outcomes Sleep Questionnaire measures subjective response</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intolerance Questionnaire</measure>
    <time_frame>2 months</time_frame>
    <description>Series of questions which are typical of patients who experience intolerance to PAP therapy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Treatment for Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Combination Therapy with Preferred Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preferred Mask refers to a type of existing medical mask used for PAP therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination Therapy with Custom Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Custom Mask refers to a mask which is supported by an interface which attaches directly to the patient's oral appliance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nuance Pro</intervention_name>
    <description>Study compares Nuance Pro plus autoPAP vs TAP PAP plus autoPAP</description>
    <arm_group_label>Combination Therapy with Preferred Mask</arm_group_label>
    <other_name>TAP PAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>autoPAP</intervention_name>
    <description>autoPAP</description>
    <arm_group_label>Combination Therapy with Custom Mask</arm_group_label>
    <arm_group_label>Combination Therapy with Preferred Mask</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAP PAP</intervention_name>
    <description>TAP PAP</description>
    <arm_group_label>Combination Therapy with Custom Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Baseline diagnosis AHI &gt; or = 5 plus ESS . or = 10.

          -  PAP Intolerance

          -  Partial Response to oral appliance therapy: AHI &gt; 5

          -  Age: &gt; 18 Exclusion Criteria: History of daily use of alcohol, narcotics or CNS
             depressants.

          -  Diagnosis of Central Sleep Apnea

          -  Pregnancy

          -  Edentulous

          -  Prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>J. Michael Adame, DDS, PA</name>
      <address>
        <city>Edinburg</city>
        <state>Texas</state>
        <zip>78539</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 19, 2019</study_first_submitted>
  <study_first_submitted_qc>July 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2019</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Adame, J. Michael, D.D.S.</investigator_affiliation>
    <investigator_full_name>Joseph Adame</investigator_full_name>
    <investigator_title>J. Michael Adame, DDS, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

